erythrosine has been researched along with Brain Disorders in 9 studies
Fluoresceins: A family of spiro(isobenzofuran-1(3H),9'-(9H)xanthen)-3-one derivatives. These are used as dyes, as indicators for various metals, and as fluorescent labels in immunoassays.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of ST1942, a 2-aminotetraline derivative with anti-inflammatory properties, was evaluated in ischemia/reperfusion injury in CD1 and C57BL/6 mice." | 3.74 | 2-Aminotetraline derivative protects from ischemia/reperfusion brain injury with a broad therapeutic window. ( Capone, C; Carminati, P; De Simoni, MG; Fabrizi, C; Fumagalli, L; Ghirardi, O; Marzorati, P; Piovesan, P; Principato, MC, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (55.56) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marazioti, A | 1 |
| Papadia, K | 1 |
| Kannavou, M | 1 |
| Spella, M | 1 |
| Basta, A | 1 |
| de Lastic, AL | 1 |
| Rodi, M | 1 |
| Mouzaki, A | 1 |
| Samiotaki, M | 1 |
| Panayotou, G | 1 |
| Stathopoulos, GT | 1 |
| Antimisiaris, SG | 1 |
| MILLER, DR | 1 |
| HALLABA, MA | 1 |
| STEEGMANN, AT | 1 |
| Lee, JC | 1 |
| Cho, GS | 1 |
| Kwon, JH | 1 |
| Shin, MH | 1 |
| Lim, JH | 1 |
| Kim, WK | 1 |
| Tanaka, KF | 1 |
| Ochi, N | 1 |
| Hayashi, T | 1 |
| Ikeda, E | 1 |
| Ikenaka, K | 1 |
| Capone, C | 1 |
| Fabrizi, C | 1 |
| Piovesan, P | 1 |
| Principato, MC | 1 |
| Marzorati, P | 1 |
| Ghirardi, O | 1 |
| Fumagalli, L | 1 |
| Carminati, P | 1 |
| De Simoni, MG | 1 |
| Coscas, G | 1 |
| Binaghi, M | 1 |
| Quentel, G | 1 |
| Sun, T | 1 |
| Greenspan, J | 1 |
| Tenenbaum, M | 1 |
| Farmer, P | 1 |
| Jones, T | 1 |
| Kaplan, M | 1 |
| Peacock, J | 1 |
| Raue, W | 1 |
| Wilcke, O | 1 |
1 review available for erythrosine and Brain Disorders
| Article | Year |
|---|---|
[Incidents and accidents in fluorescence angiography].
Topics: Brain Diseases; Cardiomyopathies; Fluorescein Angiography; Fluoresceins; Humans; Hypersensitivity; N | 1982 |
8 other studies available for erythrosine and Brain Disorders
| Article | Year |
|---|---|
Cellular Vesicles: New Insights in Engineering Methods, Interaction with Cells and Potential for Brain Targeting.
Topics: Animals; Blood-Brain Barrier; Brain; Brain Diseases; Cell Engineering; Cytoplasmic Vesicles; Drug De | 2019 |
EFFECT OF PROFOUND HYPOTHERMIA WITH CIRCULATORY ARREST IN DOGS: SPECIAL REFERENCE TO CHANGES IN CEREBROVASCULAR PERMEABILITY.
Topics: Acid-Base Equilibrium; Animals; Blood-Brain Barrier; Brain; Brain Diseases; Cerebrovascular Circulat | 1965 |
Macrophageal/microglial cell activation and cerebral injury induced by excretory-secretory products secreted by Paragonimus westermani.
Topics: Animals; Brain Diseases; Cell Death; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fluorescei | 2006 |
Fluoro-Jade: new fluorescent marker of Rosenthal fibers.
Topics: Alexander Disease; Animals; Astrocytoma; Brain; Brain Diseases; Fluoresceins; Fluorescent Antibody T | 2006 |
2-Aminotetraline derivative protects from ischemia/reperfusion brain injury with a broad therapeutic window.
Topics: Amphetamines; Animals; Behavior, Animal; Brain Diseases; Cerebrovascular Circulation; CHO Cells; Cri | 2007 |
Diagnosis of cerebral toxoplasmosis using fluorescein-labeled antitoxoplasma monoclonal antibodies.
Topics: Antibodies, Monoclonal; Azure Stains; Biopsy; Brain; Brain Diseases; Eosine Yellowish-(YS); Fluoresc | 1986 |
[On the etiology of pertussis encephalosis].
Topics: Animals; Bordetella pertussis; Brain Diseases; Capillary Permeability; Endotoxins; Fluoresceins; Inj | 1967 |
[Isotope diagnosis in neurosurgery].
Topics: Arsenic; Bismuth; Brain Diseases; Brain Neoplasms; Cerebral Hemorrhage; Cerebrovascular Circulation; | 1966 |